Ranbaxy Laboratories has taken steps to set up its third research and development (R&D) centre and global headquarters at Gurgaon in Haryana, located about 40 kms from Delhi.

The R&D III centre is estimated to entail an investment of $10 million (approx Rs.46 crore) and likely to be completed in the second quarter of 2005. The centre with a capacity of around 750 employees, will essentially focus on areas such as medicinal and process chemistry, biological screening, pre-clinical development, early clinical development, New Chemical Entities (NCEs) and Novel Drug Delivery Systems (NDDS).

Ranbaxy is also investing close to Rs.40 crore in developing its international headquarters-cum-corporate office building, also in Gurgaon. Cushman & Wakefield have been appointed as the project manager and Rajinder Kumar & Associates, as its architects.

The 2.4 lakh sq.ft. office, divided into four blocks, will accommodate about 1,000 empolyees. Civil works are now in progress with completion scheduled for September/ October 2004. The company’s offices currently in operation at various locations in Delhi will shift to the new premises after completion.